Skip to content
The Nexus
DossierENTITY

Sobi

Coverage of Sobi in the Nexus archive.

Earliest in view: Aug 3 · 11:25 UTCMost recent: Aug 3 · 11:25 UTC
Co-mentioned in this coverage
BioNTechorganization1Guido Oelkersperson1Ugur Sahinperson1Özlem Türeciperson1oncologytopic1mRNA medicinestopic1
Recent coverage
  • BUSINESSAug 3 · 11:25 UTCSTAT NEWS
    STAT+: BioNTech names Guido Oelkers its new CEO

    BioNTech appointed Guido Oelkers as its new CEO, replacing Ugur Sahin. Oelkers, a biopharma industry veteran, will lead the company's shift toward oncology and aim for multiple approved medicines by 2030. Sahin and cofounder Özlem Türeci are leaving to launch a new biotech focused on mRNA medicines.

Sobi · Dossier · The Nexus